| Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the … K Sliwa, D Hilfiker-Kleiner, MC Petrie, A Mebazaa, B Pieske, E Buchmann, ... European journal of heart failure 12 (8), 767-778, 2010 | 1341 | 2010 |
| Cardiomyocyte stiffness in diastolic heart failure A Borbély, J Van Der Velden, Z Papp, JGF Bronzwaer, I Edes, ... Circulation 111 (6), 774-781, 2005 | 711 | 2005 |
| Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain A Tóth, J Boczán, N Kedei, E Lizanecz, Z Bagi, Z Papp, I Édes, L Csiba, ... Molecular Brain Research 135 (1-2), 162-168, 2005 | 531 | 2005 |
| Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium A Borbély, I Falcao-Pires, L van Heerebeek, N Hamdani, I Edes, C Gavina, ... Circulation research 104 (6), 780-786, 2009 | 454 | 2009 |
| Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan Z Papp, I Édes, S Fruhwald, SG De Hert, M Salmenperä, H Leppikangas, ... International journal of cardiology 159 (2), 82-87, 2012 | 406 | 2012 |
| Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the … VP Harjola, W Mullens, M Banaszewski, J Bauersachs, ... European journal of heart failure 19 (7), 821-836, 2017 | 396 | 2017 |
| Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins J van der Velden, Z Papp, R Zaremba, NM Boontje, JW de Jong, VJ Owen, ... Cardiovascular research 57 (1), 37-47, 2003 | 366 | 2003 |
| The continuous heart failure spectrum: moving beyond an ejection fraction classification F Triposkiadis, J Butler, FM Abboud, PW Armstrong, S Adamopoulos, ... European heart journal 40 (26), 2155-2163, 2019 | 275 | 2019 |
| Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and … D Kolijn, S Pabel, Y Tian, M Lódi, M Herwig, A Carrizzo, S Zhazykbayeva, ... Cardiovascular research 117 (2), 495-507, 2021 | 270 | 2021 |
| Treatments targeting inotropy: a position paper of the Committees on Translational Research and Acute Heart Failure of the Heart Failure Association of the European Society of … C Maack, T Eschenhagen, N Hamdani, FR Heinzel, AR Lyon, ... European heart journal 40 (44), 3626-3644, 2019 | 212 | 2019 |
| Pharmacological mechanisms contributing to the clinical efficacy of levosimendan Z Papp, K Csapó, P Pollesello, H Haikala, I Édes Cardiovascular drug reviews 23 (1), 71-98, 2005 | 189 | 2005 |
| The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig S Szilágyi, P Pollesello, J Levijoki, P Kaheinen, H Haikala, I Édes, Z Papp European journal of pharmacology 486 (1), 67-74, 2004 | 174 | 2004 |
| Tissue-specific regulation of microvascular diameter: opposite functional roles of neuronal and smooth muscle located vanilloid receptor-1 T Kark, Z Bagi, E Lizanecz, ET Pásztor, N Erdei, Á Czikora, Z Papp, I Édes, ... Molecular pharmacology 73 (5), 1405-1412, 2008 | 162 | 2008 |
| The effect of myosin light chain 2 dephosphorylation on Ca2+-sensitivity of force is enhanced in failing human hearts J van der Velden, Z Papp, NM Boontje, R Zaremba, JW de Jong, ... Cardiovascular research 57 (2), 505-514, 2003 | 159 | 2003 |
| The cardioprotective effects of levosimendan: preclinical and clinical evidence P Pollesello, Z Papp Journal of cardiovascular pharmacology 50 (3), 257-263, 2007 | 158 | 2007 |
| Levosimendan beyond inotropy and acute heart failure: evidence of pleiotropic effects on the heart and other organs: an expert panel position paper D Farmakis, J Alvarez, TB Gal, D Brito, F Fedele, C Fonseca, AC Gordon, ... International Journal of Cardiology 222, 303-312, 2016 | 157 | 2016 |
| Levosimendan efficacy and safety: 20 years of SIMDAX in clinical use Z Papp, P Agostoni, J Alvarez, D Bettex, S Bouchez, D Brito, V Černý, ... Journal of cardiovascular pharmacology 76 (1), 4-22, 2020 | 153 | 2020 |
| High-fat diet-induced reduction in nitric oxide-dependent arteriolar dilation in rats: role of xanthine oxidase-derived superoxide anion N Erdei, A Tóth, ET Pásztor, Z Papp, I Edes, A Koller, Z Bagi American journal of physiology-heart and circulatory physiology 291 (5 …, 2006 | 137 | 2006 |
| The levosimendan metabolite OR‐1896 elicits vasodilation by activating the KATP and BKCa channels in rat isolated arterioles N Erdei, Z Papp, P Pollesello, I Édes, Z Bagi British journal of pharmacology 148 (5), 696-702, 2006 | 128 | 2006 |
| Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in … PM Seferović, S Stoerk, G Filippatos, V Mareev, A Kavoliuniene, AD Ristić, ... European journal of heart failure 15 (9), 947-959, 2013 | 118 | 2013 |
Istvan EdesProfessor of Cardiology, Institute of Cardiology, University of Debrecen, HungaryE-mail megerősítve itt: med.unideb.hu
